PARP inhibitors for cancer therapy / Nicola J. Curtin, Ricky A. Sharma, editors.

"PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PARP (poly ADP ribose polymerase) and its role in DNA repair. In addition, a description of discovery of the PARP family, and other DNA...

Full description

Saved in:
Bibliographic Details
Other Authors: Curtin, Nicola J. (Editor), Sharma, Ricky A. (Editor)
Format: Ebook
Language:English
Published: Cham : Humana Press : Springer, [2015]
Series:Cancer drug discovery and development ; v. 83.
Subjects:
Online Access:Springer eBooks
Description
Summary:"PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PARP (poly ADP ribose polymerase) and its role in DNA repair. In addition, a description of discovery of the PARP family, and other DNA maintenance-associated PARPs will also be discussed. The volume also features a section on accessible chemistry behind the development of inhibitors.PARP inhibitors are a group of pharmacological inhibitors that are a particularly good target for cancer therapy. PARP plays a pivotal role in DNA repair and may contribute to the therapeutic resistance to DNA damaging agents used to treat cancer. Researchers have learned a tremendous amount about the biology of PARP and how tumour-specific defects in DNA repair can be exploited by PARPi. The “synthetic lethality” of PARPi is an exciting concept for cancer therapy and has led to a heightened activity in this area."--Publisher's website.
Physical Description:1 online resource (xix, 591 pages).
Bibliography:Includes bibliographical references and index.
ISBN:3319141511
9783319141510
Availability
Requests
Request this item Request this AUT item so you can pick it up when you're at the library.
Interlibrary Loan With Interlibrary Loan you can request the item from another library. It's a free service.